TABLE 2.
Comparisons of primary outcomes among guidance modalities included in the network meta-analysis.
| OR (95% CrI) | OR (95% CrI) | OR (95% CrI) | |
| MACE | |||
| CAG | 0.60 (0.46, 0.79) | 0.68 (0.43, 1.10) | 0.87 (0.70, 1.10) |
| IVUS | 1.11 (0.72, 1.73) | 1.44 (1.03, 2.08) | |
| OCT/OFDI | 1.30 (0.82, 2.07) | ||
| FFR/QFR | |||
| Cardiovascular death | |||
| CAG | 0.46 (0.20, 0.94) | 1.40 (0.09, 37.00) | 0.90 (0.48, 1.80) |
| IVUS | 2.96 (0.20, 77.72) | 1.96 (0.73, 5.96) | |
| OCT/OFDI | 0.66 (0.02, 11.01) | ||
| FFR/QFR | |||
| Myocardial infarction | |||
| CAG | 0.87 (0.54, 1.40) | 0.75 (0.35, 1.50) | 0.80 (0.58, 1.20) |
| IVUS | 0.86 (0.41, 1.79) | 0.92 (0.54, 1.76) | |
| OCT/OFDI | 1.07 (0.52, 2.38) | ||
| FFR/QFR | |||
| TVR/TLR | |||
| CAG | 0.55 (0.41, 0.74) | 0.73 (0.43, 1.20) | 0.93 (0.61, 1.40) |
| IVUS | 1.33 (0.79, 2.22) | 1.68 (1.02, 2.83) | |
| OCT/OFDI | 1.26 (0.68, 2.44) | ||
| FFR/QFR | |||